SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-052552
Filing Date
2021-04-20
Accepted
2021-04-20 16:30:24
Documents
3
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212634d1_def14a.htm DEF 14A 396353
2 GRAPHIC tm212634d1_def14aimg01.gif GRAPHIC 42248
3 GRAPHIC tm212634d1_def14aimg02.gif GRAPHIC 84423
  Complete submission text file 0001104659-21-052552.txt   572276
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34058 | Film No.: 21838214
SIC: 2834 Pharmaceutical Preparations